Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122448) titled 'The Role of *Streptococcus parasanguinis* B in Allergen-Specific Immunotherapy for Pediatric Allergic Rhinitis and Its Potential as a Novel Biomarker' on April 14.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Fujian Children's Hospital
Condition:
Allergic Rhinitis
Intervention:
Children with allergic rhinitis:none
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: Children with allergic rhinitis:40;control group:22;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?p...